{Reference Type}: Journal Article
{Title}: In brief: Retifanlimab (Zynyz) for Merkel cell carcinoma.
{Journal}: Med Lett Drugs Ther
{Volume}: 65
{Issue}: 1674
{Year}: 04 2023 17
{Factor}: 1.677
{DOI}: 10.58347/tml.2023.1674h
{Abstract}: